http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010006149-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 1998-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010006149-A |
| titleOfInvention | Novel 4-Halogenated Steroids, Preparation Method and Intermediates, Application as Medicines and Pharmaceutical Compositions Containing Same |
| abstract | The gist of the present invention is a compound represented by the following general formula (I), a preparation method and an intermediate thereof, their use as a medicine and a composition containing them.n n n (Ⅰ)n n n Wherein X is a halogen atom, D has an optionally unsaturated bond as the residue of an optionally substituted pentagonal or hexagonal ring, and R 1 , R 2 , R 3 , R 4 , Y and n are the details of the invention As defined in the description). |
| priorityDate | 1997-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.